Clinical Trial Update: Reduced Intensity Haploidentical Transplant for Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update presents results from Phase 1 and Phase 2 studies of reduced-intensity haploidentical transplantation for hematological malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-01-15